ALSO NOTED: Shire drug gets second approvable letter; Galapagos acquires ProStrakan sub; FDA asks Allergan for more data; and m

> The FDA has issued its second approvable letter for Shire's ADHD drug Vyvanse. Report [1]

> Galapagos has acquired ProSkelia, a French subsidiary of ProStrakan in a deal worth up to €45 million. Report [2] 

> Allergan has announced that the FDA has asked for more data on its eye pressure medication Combigan. Report [3]

> The FDA has approved Novartis' Exforge for high blood pressure. Release [4]

> Protiva Biotherapeutics has filed an appeal that seeks to overturn the BC Supreme Court's ruling that would permit Inex Pharmaceuticals Corporation to transfer the Inex-Protiva agreements to Tekmira Corporation without Protiva's consent. Release [5]

And Finally... Drug reps will face a tough year in 2007. Report [6]